A Randomized Double Blind Controlled Safety Trial Evaluating D-Lactic Acid Production in Healthy Infants Fed a -containing Formula
Background D-Lactic acidosis in infants fed lactic acid bacteria-containing products is a concern. Methods The primary objective of this non-inferiority trial was to compare urinary D-lactic acid concentrations during the first 28 days of life in infants fed formula containing Lactobacillus reuteri...
Main Authors: | Konstantinos Papagaroufalis, Aikaterini Fotiou, Delphine Egli, Liên-Anh Tran, Philippe Steenhout |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2014-01-01
|
Series: | Nutrition and Metabolic Insights |
Online Access: | https://doi.org/10.4137/NMI.S14113 |
Similar Items
-
A Randomized Double Blind Controlled Safety Trial Evaluating D-Lactic Acid Production in Healthy Infants Fed a Lactobacillus reuteri-containing Formula
by: Konstantinos Papagaroufalis, et al.
Published: (2014-04-01) -
Growth of Infants Fed Formula with Evolving Nutrition Composition: A Single‐Arm Non‐Inferiority Study
by: Johannes Spalinger, et al.
Published: (2017-03-01) -
Early Benefits of a Starter Formula Enriched in Prebiotics and Probiotics on the Gut Microbiota of Healthy Infants Born to HIV+ Mothers: A Randomized Double-Blind Controlled Trial
by: Peter Cooper, et al.
Published: (2016-01-01) -
Growth and tolerance of healthy, term infants fed lower protein extensively hydrolyzed or amino acid-based formula: double-blind, randomized, controlled trial
by: Craig B. Adams, et al.
Published: (2021-07-01) -
Growth and tolerance of infants fed formula supplemented with polydextrose (PDX) and/or galactooligosaccharides (GOS): double-blind, randomized, controlled trial
by: Ashley Claude, et al.
Published: (2012-06-01)